MP22-07CONTEMPORARY CONDITIONAL CANCER-SPECIFIC SURVIVAL RATES IN SURGICALLY TREATED NON-METASTATIC PRIMARY URETHRAL CARCINOMAdoi:10.1097/01.JU.0001008608.50694.4b.07Simone MorraLukas ScheipnerAndrea BaudoLetizia M. I. JannelloMario De AngelisCarolin Siech...
Using the CORONA database, comprising 6234 patients treated with radical or partial nephrectomy, women had significantly better disease-specific (HR 0.75) and overall (HR 0.80) survival rates than their male counterparts.51 In a SEER-based study, Aaron et al. also reported a better overal...
Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer The 5-year breast cancer-specific survival rates of patients who underwent BCT, a mastectomy alone, or a mastectomy with radiation were 97%, 94%, and... S Agarwal,L Pappas,L Neumayer...
Overall and cancer-specific survival rates up to 5years were calculated. A total of 871 patients were included. At 5years, cancer-specific survival was 81.9% and overall survival was 65.6%. On multivariate analysis, age ≥75years (hazard ratio (HR) 2.11, 95% confidence intervals (CI) 1.57...
The 5- and 10-year biochemical recurrence-free survival rates were 73.2% and 66.2%, respectively, and the 10-year cancer-specific survival rate was 92.4%. The mean time from surgery to biochemical recurrence was 18 months. In the multivariate analysis, Gleason score (4+3 vs. 2-6, p=...
Women with early-stage breast cancers are expected to have excellent survival rates. It is important to identify factors that predict diagnosis of early-st... C.L. Roland MD,K.K. Hunt MD - 《Breast Diseases A Year Book Quarterly》 被引量: 142发表: 2015年 Differences in Breast Cancer Sta...
Among a racially diverse cohort of men and women with CRC, believing in the curability of cancer was independently associated with survival over a 15-year period. Confirmation of the role of cancer-specific beliefs on survival and study of the potential biobehavioral mechanisms is needed. Findings...
ObjectiveToexplorewhetherdiagnosticprogressioneffectscancerspecificmortality,incidenceand5yearsurvivalrates. 目的探讨诊断技术进步对肿瘤发病率、死亡率和5年生存率带来的影响。 www.chemyq.com 7. Overall,cancerspecificsurvivalat5-yearsforthiscohortwas48%.
The prognostic factors for survival among patients with secondary osteosarcoma remain unclear. The aim of this study was to develop a practical nomogram for predicting cancer-specific survival (CSS) in patients with osteosarcoma as a secondary malignancy. The surveillance, epidemiology, and end results...
Conclusion: IHSCS eligibility at the time of diagnosis does not seem to facilitate early Medicaid enrollment. Impact: Because cancer survival rates in AIANs are among the lowest of any racial group, additional research is needed to identify factors that improve access to care in AIANs. 展开 ...